Development and external validation of a novel nomogram to predict prostate cancer in biopsy‐naïve patients with PSA <10 ng/ml and PI‐RADS v2.1 = 3 lesions

OBJECTIVE: To develop and externally validate a novel nomogram in biopsy‐naïve patients with prostate‐specific antigen (PSA) <10 ng/ml and PI‐RADS v2.1 = 3 lesions. METHODS: We retrospectively collected 307 men that underwent initial biopsy from October 2015 to January 2022 in Cohort 1 (The First...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Can, Sun, Jiale, Xu, Zhenyu, Zhang, Zhiyu, Zhou, Qi, Xu, Jiangnan, Chen, Hao, Wang, Chao, Ouyang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939143/
https://www.ncbi.nlm.nih.gov/pubmed/35920264
http://dx.doi.org/10.1002/cam4.5100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939143/
https://www.ncbi.nlm.nih.gov/pubmed/35920264
http://dx.doi.org/10.1002/cam4.5100

Ejemplares similares